breathspec device_copy.jpg
 

A rapid, non-invasive, cost-effective, analytical device for bacterial or viral infection diagnosis through ultra-high sensitivity breath analysis.  

 

 
 

our mission 

Antibiotic resistant bacteria cause of more than 25,000 premature deaths in Europe every year.

 

So far, a global consumption of antibiotics increased by 40% in the last decade has been doing nothing but aggravating the problem. Antibiotics are becoming less effective and the risk for the near future is to become dangerously exposed to infectious diseases.

In this sense, breath analysis is receiving ever increasing attention as it provides a non-invasive clinical test that can be used for early disease detection. In the future, rapid breath diagnostics should be able to allow doctors prescribing the most appropriate available medicine, so to protect our most valuable drugs from over-consumption.

 

IMG_2450.JPG

The BreathSpec® project aims to develop a rapid, non-invasive device that can diagnose bacterial or viral infections through ultra-high sensitivity breath analysis.  

Call identifier

FTIPilot-01-2016 - Fast Track to Innovation

Duration

27 months

Starting Date

May 1, 2017

Project Number

755667 

The consortium 

 
 

News 

Read about the project in Business News Wales

social

FOLLOW THE PROJECT ALSO ON OUR LinkedIn SHOWCASE!

BreathSpec

 

Contact us 

Name *
Name